NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

NOVO.B.DK

249.05

+1.47%↑

GMAB.DK

1,779.5

-0.64%↓

HLUNB.DK

38.16

-0.21%↓

ZEAL.DK

369.8

-0.7%↓

AMBUB.DK

76.8

-2.35%↓

Search

Coloplast A-S (Class B)

Fermé

463.9 -0.69

Résumé

Variation du prix de l'action

24h

Actuel

Min

458.6

Max

467.1

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

27.175

66.845

BPA

6.32

Rendement du dividende

4.74

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

4.74%

2.25%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-10B

108B

Ouverture précédente

464.59

Clôture précédente

463.9

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

4 mars 2026, 23:39 UTC

Actions en Tendance

Stocks to Watch: Broadcom, StubHub, PepGen, Veeva Systems

4 mars 2026, 23:20 UTC

Résultats

Broadcom Sales Rise as AI Developers Build More Products and Agents -- Update

4 mars 2026, 21:43 UTC

Résultats

Broadcom Logs Higher Sales, Authorizes $10 Billion Buyback Amid Climbing AI Demand

4 mars 2026, 23:48 UTC

Market Talk

Nikkei May Rise After Recent Selloffs -- Market Talk

4 mars 2026, 23:33 UTC

Market Talk
Principaux Événements d'Actualité

Gold Edges Higher Amid Ongoing U.S.-Iran Conflict -- Market Talk

4 mars 2026, 23:24 UTC

Market Talk

RBA on Track to Raise Rates, but What's the Rush? -- Market Talk

4 mars 2026, 22:30 UTC

Résultats

Ecopetrol: Distribution Equivalent to a Payout of 50.1% of Ecopetrol S.A.'s Net Income in 2025 >EC

4 mars 2026, 22:30 UTC

Résultats

Ecopetrol: Payment of Dividends Proposed to Be Made No Later Than April 30 >EC

4 mars 2026, 22:30 UTC

Résultats

Ecopetrol: Earnings Distribution Proposes Ordinary Div Distribution of COP110 per Shr >EC

4 mars 2026, 22:13 UTC

Résultats

Vermilion Energy: Expects Full-Yr Production of 118,000 to 122,000 Boe/d (70% Natural Gas) >VET

4 mars 2026, 22:13 UTC

Résultats

Vermilion Energy: Expects 1Q Production to Avg 122,000 to 124,000 Boe/d (70% Natural Gas) >VET

4 mars 2026, 22:13 UTC

Résultats

Vermilion Energy 4Q EPS C$2.86 >VET

4 mars 2026, 22:04 UTC

Market Talk

RBA Slipping Behind The Curve On Rates -- Market Talk

4 mars 2026, 21:53 UTC

Résultats

Lithium Americas 4Q Rev $66.8M >LAC

4 mars 2026, 21:53 UTC

Résultats

Lithium Americas 4Q Loss/Shr 52c >LAC

4 mars 2026, 21:52 UTC

Résultats

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mars 2026, 21:50 UTC

Résultats

These Stocks Are Today's Movers: Moderna, Coinbase, Strategy, CoreWeave, Micron, Sandisk, GitLab, and More -- Barrons.com

4 mars 2026, 21:50 UTC

Market Talk

Tech, Media & Telecom Roundup: Market Talk

4 mars 2026, 21:48 UTC

Résultats

Webull 4Q Rev $165.2M >BULL

4 mars 2026, 21:48 UTC

Résultats

Webull 4Q EPS 1c >BULL

4 mars 2026, 21:45 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

4 mars 2026, 21:45 UTC

Market Talk

Canada Officials Might Need to Intervene to Spur Home Building -- Market Talk

4 mars 2026, 21:40 UTC

Résultats

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mars 2026, 21:36 UTC

Principaux Événements d'Actualité

Iran Conflict Spurs Rebound in U.S. Borrowing Costs -- Update

4 mars 2026, 21:27 UTC

Résultats

Broadcom Earnings Beat Estimates as AI Demand Remains Strong -- Barrons.com

4 mars 2026, 21:17 UTC

Market Talk

Energy Price Volatility Boosts Case for Climate-Tech Startups -- Market Talk

4 mars 2026, 21:16 UTC

Résultats

Broadcom: Board Authorizes Share-Repurchase Program for Up to $10B of Common Stock >AVGO

4 mars 2026, 21:15 UTC

Résultats

Broadcom 1Q EPS $1.50 >AVGO

4 mars 2026, 21:15 UTC

Résultats

Broadcom 1Q Net $7.35B >AVGO

4 mars 2026, 21:15 UTC

Résultats

Broadcom 1Q Rev $19.31B >AVGO

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat